Salesforce, Inc.
CRM
$187.18
+0.50%
Salesforce, Inc. is a leading provider of enterprise cloud computing and customer relationship management (CRM) solutions. The company is defined by its dominant Customer 360 platform, which integrates data across systems to help businesses sell, service, market, and conduct commerce.…
CRM
Salesforce, Inc.
$187.18
Related headlines
CRM 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Salesforce, Inc.'s 12-month outlook, with a consensus price target around $243.33 and implied upside of +30.0% versus the current price.
Average Target
$243.33
18 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
18
covering this stock
Price Range
$150 - $243
Analyst target range
Wall Street analyst coverage for Salesforce is active, with 18 analysts providing estimates. The consensus estimates for the upcoming period are an average EPS of $19.62 (range $19.24 to $20.34) and average revenue of $60.78 billion (range $59.88B to $62.51B). Recent institutional ratings from firms like Piper Sandler, TD Cowen, Stifel, Needham, and JP Morgan maintain 'Buy' or 'Overweight' stances, while others like Citigroup, DA Davidson, Wells Fargo, and Macquarie have 'Neutral' or equivalent ratings. This indicates a mixed but generally supportive analyst view.
CRM Technical Analysis
The stock has experienced a significant downtrend over the observed period, falling from a high near $266 in late December 2025 to a low of $178.16 in late February 2026. The 1-month and 3-month price changes are -4.17% and -29.53%, respectively, significantly underperforming the S&P 500, which declined -5.25% and -4.63% over the same periods. The stock's relative strength readings are negative, at -24.90 over 3 months, indicating persistent weakness. The current price of $186.67 is positioned near the lower end of its 52-week range of $174.57 to $296.05, representing a drawdown of approximately -42% from the high. The price has stabilized somewhat in March 2026, trading in a range roughly between $179 and $202, but remains well below its recent peaks. The stock's beta of 1.307 indicates it is more volatile than the broader market. The recent price action shows consolidation after a steep decline, but the overall technical picture remains bearish given the magnitude of the drawdown and sustained underperformance against the market.
Beta
1.31
1.31x market volatility
Max Drawdown
-42.0%
Largest decline past year
52-Week Range
$175-$296
Price range past year
Annual Return
-31.1%
Cumulative gain past year
| Period | CRM Return | S&P 500 |
|---|---|---|
| 1m | -4.5% | -3.6% |
| 3m | -26.2% | -4.0% |
| 6m | -22.1% | -2.0% |
| 1y | -31.1% | +16.2% |
| ytd | -26.2% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRM Fundamental Analysis
Revenue growth remains solid, with the latest quarterly revenue of $11.20 billion representing a 12.1% year-over-year increase. Profitability metrics are strong, with a net margin of 17.35% and an operating margin of 21.47% for the quarter. The company maintains a robust gross margin of 77.61%, highlighting the high-margin nature of its software business. Financial health is sound, supported by a manageable debt-to-equity ratio of 0.29 and substantial free cash flow generation, with TTM free cash flow of $14.40 billion. The current ratio is low at 0.76, which is typical for asset-light software companies but warrants monitoring for liquidity management. Operational efficiency is demonstrated by a Return on Equity (ROE) of 12.61% and a Return on Assets (ROA) of 5.18%. The company's asset turnover and cash flow generation indicate effective use of capital to drive shareholder returns.
Quarterly Revenue
$11.2B
2026-01
Revenue YoY Growth
+0.12%
YoY Comparison
Gross Margin
+0.77%
Latest Quarter
Free Cash Flow
$14.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRM Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is 27.05, while the forward P/E is 12.53, suggesting the market expects significant earnings growth. The PEG ratio of 1.24, based on this forward earnings estimate, indicates the stock may be fairly valued relative to its growth prospects. Other valuation multiples include a Price-to-Sales (P/S) ratio of 4.86 and an Enterprise Value-to-Sales (EV/Sales) ratio of 4.35. The Price-to-Book (P/B) ratio is 3.41. Peer comparison data is not available in the provided inputs to contextualize these multiples against industry averages.
PE
27.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -2046x~1557x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.1x
Enterprise Value Multiple

